• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular Interventions, Other  • Oncology  • Skin Cancer  • Dermatology  • Dermatologic Disorders  • Patient-Physician Relationship/ Care  • Patient Education/ Health Literacy  • Cardiovascular System  • Surgery  • Surgical Interventions  • Cardiovascular/ Cardiothoracic Surgery  • Neoplasms  • Transplantation  • Cardiac Transplantation  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

Jerry D. Brewer, MD; Oscar R. Colegio, MD, PhD; P. Kim Phillips, MD; Randall K. Roenigk, MD; M. Amanda Jacobs, MD; Diederik Van de Beek, MD, PhD; Ross A. Dierkhising, MS; Walter K. Kremers, PhD; Christopher G. A. McGregor, MD; Clark C. Otley, MD

Arch Dermatol. 2009;145(12):1391-1396.

Objective  To examine the incidence, tumor burden, and risk factors for nonmelanoma and other skin cancer types in this heart transplant cohort.

Design  Retrospective review of patient medical records.

Setting  Tertiary care center.

Patients  All heart transplant recipients at Mayo Clinic from 1988 to 2006.

Main Outcome Measures  Cumulative incidence of skin cancer and tumor burden, with Cox proportional hazards regression models used to evaluate risk factors for posttransplant primary and secondary nonmelanoma skin cancer.

Results  In total, 312 heart transplant patients had 1395 new skin cancers in 2097 person-years (mean, 0.43 per year per patient) with a range of 0 to 306 for squamous cell carcinoma (SCC) and 0 to 17 for basal cell carcinoma (BCC). The cumulative incidence rates of any skin cancer were 20.4%, 37.5%, and 46.4% at 5, 10, and 15 years after heart transplant, respectively. Cumulative incidence of SCC after the first BCC was 98.1% within 7 years. Multivariate analysis showed that posttransplant nonskin cancer, increased age, and heart failure etiologic factors other than idiopathic disease were associated with increased risk of SCC. Posttransplant herpes simplex viral infection, increased age, and use of mycophenolate mofetil for immunosuppression were associated with increased risk of BCC.

Conclusions  With prolonged survival, many heart transplant patients have numerous skin cancers. Vigilant sun protection practices, skin cancer education, and regular skin examination are appropriate interventions in these high-risk patients.

Author Affiliations: Divisions of Dermatologic Surgery (Drs Brewer, Phillips, Roenigk, Jacobs, and Otley), Infectious Diseases (Dr Van de Beek), and Biomedical Informatics and Biostatistics (Mr Dierkhising and Dr Kremers), and Department of Surgery (Dr McGregor), Mayo Clinic, Rochester, Minnesota; and Department of Dermatology, Yale School of Medicine, New Haven, Connecticut (Dr Colegio).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Skin Cancer in Heart Transplant Recipients
Journal Watch Dermatology 2009;2009:2-2.
FULL TEXT